Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Solans

Showing results (61-70 of 69) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 69 results.
Revista Clinica Espanola|May 11, 2001
[Proptosis and orbital tumor in an 80-year old woman. Primary orbital amyloidosis]F Martínez del Valle, A Selva O'Callaghan, R Solans Laque, et al.
Lupus|September 1, 2005
Polymyositis/dermatomyositis-associated lung disease: analysis of a series of 81 patientsA Selva-O'Callaghan, M Labrador-Horrillo, X Muñoz-Gall, et al.
Revista Clinica Espanola|June 29, 2025
Expert consensus on interstitial lung disease associated with systemic autoimmune diseases. Executive summaryA González-García, M Akasbi, M P Brito-Zerón, et al.
Clinical and Experimental Rheumatology|January 12, 2013
A case-control study suggests that the CCR6 locus is not involved in the susceptibility to giant cell arteritisA Serrano, F D Carmona, S Castañeda, et al.
European Journal of Internal Medicine|June 16, 2024
Red flags for clinical suspicion of eosinophilic granulomatosis with polyangiitis (EGPA)R Solans-Laqué, I Rúa-Figueroa, M Blanco Aparicio, et al.
International Immunopharmacology|April 23, 2015
How are we treating our systemic patients with primary Sjögren syndrome? Analysis of 1120 patientsH Gheitasi, B Kostov, R Solans, et al.
Annals of the Rheumatic Diseases|November 30, 2014
Systemic activity and mortality in primary Sjögren syndrome: predicting survival using the EULAR-SS Disease Activity Index (ESSDAI) in 1045 patientsP Brito-Zerón, B Kostov, R Solans, et al.
Annals of the Rheumatic Diseases|August 16, 2013
Identification of the PTPN22 functional variant R620W as susceptibility genetic factor for giant cell arteritisA Serrano, A Márquez, S L Mackie, et al.
Annals of the Rheumatic Diseases|June 13, 2014
Influence of the IL17A locus in giant cell arteritis susceptibilityA Márquez, J Hernández-Rodríguez, M C Cid, et al.
Pageof 7

Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
Revista Clinica Espanola|May 11, 2001
[Proptosis and orbital tumor in an 80-year old woman. Primary orbital amyloidosis]F Martínez del Valle, A Selva O'Callaghan, R Solans Laque, et al.
Lupus|September 1, 2005
Polymyositis/dermatomyositis-associated lung disease: analysis of a series of 81 patientsA Selva-O'Callaghan, M Labrador-Horrillo, X Muñoz-Gall, et al.
Revista Clinica Espanola|June 29, 2025
Expert consensus on interstitial lung disease associated with systemic autoimmune diseases. Executive summaryA González-García, M Akasbi, M P Brito-Zerón, et al.
Clinical and Experimental Rheumatology|January 12, 2013
A case-control study suggests that the CCR6 locus is not involved in the susceptibility to giant cell arteritisA Serrano, F D Carmona, S Castañeda, et al.
European Journal of Internal Medicine|June 16, 2024
Red flags for clinical suspicion of eosinophilic granulomatosis with polyangiitis (EGPA)R Solans-Laqué, I Rúa-Figueroa, M Blanco Aparicio, et al.
International Immunopharmacology|April 23, 2015
How are we treating our systemic patients with primary Sjögren syndrome? Analysis of 1120 patientsH Gheitasi, B Kostov, R Solans, et al.
Annals of the Rheumatic Diseases|November 30, 2014
Systemic activity and mortality in primary Sjögren syndrome: predicting survival using the EULAR-SS Disease Activity Index (ESSDAI) in 1045 patientsP Brito-Zerón, B Kostov, R Solans, et al.
Annals of the Rheumatic Diseases|August 16, 2013
Identification of the PTPN22 functional variant R620W as susceptibility genetic factor for giant cell arteritisA Serrano, A Márquez, S L Mackie, et al.
Annals of the Rheumatic Diseases|June 13, 2014
Influence of the IL17A locus in giant cell arteritis susceptibilityA Márquez, J Hernández-Rodríguez, M C Cid, et al.
Pageof 7